# Cardinal Health Inc: financial statements, quarterly

CAH · NYSE · CIK 721371 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/cah.md) · [Financials](/companies/cah/financials.md) · [Filings](/companies/cah/filings.md) · [Insiders](/companies/cah/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cah/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-03-31) | Q4 FY2023 (2023-06-30) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [50.5](/filings/0000721371-24-000056.md) | [53.4 d](/filings/0000721371-25-000079.md) | [54.7](/filings/0000721371-24-000121.md) | [57.4](/filings/0000721371-25-000013.md) | [54.9](/filings/0000721371-25-000038.md) | [59.9 d](/filings/0000721371-26-000038.md) | [52.3](/filings/0000721371-25-000130.md) | [55.3](/filings/0000721371-26-000006.md) | [54.9](/filings/0000721371-25-000038.md) | [60.2 d](/filings/0000721371-26-000038.md) | [64.0](/filings/0000721371-25-000130.md) | [65.6](/filings/0000721371-26-000006.md) |
| Cost of revenue | $bn | [48.7](/filings/0000721371-24-000056.md) | [51.6 d](/filings/0000721371-25-000079.md) | [52.9](/filings/0000721371-24-000121.md) | [55.6](/filings/0000721371-25-000013.md) | [52.9](/filings/0000721371-25-000038.md) | [58.0 d](/filings/0000721371-26-000038.md) | [50.4](/filings/0000721371-25-000130.md) | [53.3](/filings/0000721371-26-000006.md) | [52.8](/filings/0000721371-25-000038.md) | [58.0 d](/filings/0000721371-26-000038.md) | [61.7](/filings/0000721371-25-000130.md) | [63.2](/filings/0000721371-26-000006.md) |
| Gross profit | $bn | [1.8](/filings/0000721371-24-000056.md) | [1.8 d](/filings/0000721371-25-000079.md) | [1.7](/filings/0000721371-24-000121.md) | [1.9](/filings/0000721371-25-000013.md) | [1.9](/filings/0000721371-25-000038.md) | [1.9 d](/filings/0000721371-26-000038.md) | [1.9](/filings/0000721371-25-000130.md) | [1.9](/filings/0000721371-26-000006.md) | [2.1](/filings/0000721371-25-000038.md) | [2.2 d](/filings/0000721371-26-000038.md) | [2.3](/filings/0000721371-25-000130.md) | [2.4](/filings/0000721371-26-000006.md) |
| Selling, general and administrative | $bn | [1.2](/filings/0000721371-24-000056.md) | [1.2 d](/filings/0000721371-25-000079.md) | [1.2](/filings/0000721371-24-000121.md) | [1.3](/filings/0000721371-25-000013.md) | [1.3](/filings/0000721371-25-000038.md) | [1.3 d](/filings/0000721371-26-000038.md) | [1.3](/filings/0000721371-25-000130.md) | [1.3](/filings/0000721371-26-000006.md) | [1.3](/filings/0000721371-25-000038.md) | [1.5 d](/filings/0000721371-26-000038.md) | [1.5](/filings/0000721371-25-000130.md) | [1.5](/filings/0000721371-26-000006.md) |
| Operating income | $bn | [0.6](/filings/0000721371-24-000056.md) | [0.2 d](/filings/0000721371-25-000079.md) | [(0.0)](/filings/0000721371-24-000121.md) | [0.5](/filings/0000721371-25-000013.md) | [0.4](/filings/0000721371-25-000038.md) | [0.4 d](/filings/0000721371-26-000038.md) | [0.6](/filings/0000721371-25-000130.md) | [0.5](/filings/0000721371-26-000006.md) | [0.7](/filings/0000721371-25-000038.md) | [0.4 d](/filings/0000721371-26-000038.md) | [0.7](/filings/0000721371-25-000130.md) | [0.7](/filings/0000721371-26-000006.md) |
| Interest expense | $bn | [0.0](/filings/0000721371-24-000056.md) | [0.0 d](/filings/0000721371-25-000079.md) | [0.0](/filings/0000721371-24-000121.md) | [0.0](/filings/0000721371-25-000013.md) | [0.0](/filings/0000721371-25-000038.md) | [0.0 d](/filings/0000721371-26-000038.md) | [0.0](/filings/0000721371-25-000130.md) | [0.0](/filings/0000721371-26-000006.md) | [0.1](/filings/0000721371-25-000038.md) | [0.1 d](/filings/0000721371-26-000038.md) | [0.1](/filings/0000721371-25-000130.md) | [0.1](/filings/0000721371-26-000006.md) |
| Income tax | $bn | [0.2](/filings/0000721371-24-000056.md) | [0.1 d](/filings/0000721371-25-000079.md) | [(0.0)](/filings/0000721371-24-000121.md) | [0.1](/filings/0000721371-25-000013.md) | [0.1](/filings/0000721371-25-000038.md) | [0.2 d](/filings/0000721371-26-000038.md) | [0.1](/filings/0000721371-25-000130.md) | [0.1](/filings/0000721371-26-000006.md) | [0.2](/filings/0000721371-25-000038.md) | [0.1 d](/filings/0000721371-26-000038.md) | [0.1](/filings/0000721371-25-000130.md) | [0.2](/filings/0000721371-26-000006.md) |
| Net income | $bn | [0.4](/filings/0000721371-24-000056.md) | [0.0 d](/filings/0000721371-25-000079.md) | [(0.0)](/filings/0000721371-24-000121.md) | [0.4](/filings/0000721371-25-000013.md) | [0.3](/filings/0000721371-25-000038.md) | [0.2 d](/filings/0000721371-26-000038.md) | [0.4](/filings/0000721371-25-000130.md) | [0.4](/filings/0000721371-26-000006.md) | [0.5](/filings/0000721371-25-000038.md) | [0.2 d](/filings/0000721371-26-000038.md) | [0.5](/filings/0000721371-25-000130.md) | [0.5](/filings/0000721371-26-000006.md) |
| Diluted EPS | $ per share | [1.41](/filings/0000721371-24-000056.md) | not reported | [(0.05)](/filings/0000721371-24-000121.md) | [1.50](/filings/0000721371-24-000056.md) | [1.07](/filings/0000721371-24-000056.md) | not reported | [1.70](/filings/0000721371-25-000130.md) | not reported | not reported | not reported | [1.88](/filings/0000721371-25-000130.md) | not reported |
| Basic EPS | $ per share | [1.43](/filings/0000721371-24-000056.md) | not reported | [(0.05)](/filings/0000721371-24-000121.md) | [1.50](/filings/0000721371-24-000056.md) | [1.07](/filings/0000721371-24-000056.md) | not reported | [1.71](/filings/0000721371-25-000130.md) | not reported | not reported | not reported | [1.89](/filings/0000721371-25-000130.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-06-30) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.1](/filings/0000721371-24-000056.md) | [3.9](/filings/0000721371-23-000084.md) | [4.6](/filings/0001628280-24-002813.md) | [3.7](/filings/0000721371-24-000038.md) | [5.1](/filings/0000721371-25-000079.md) | [2.9](/filings/0000721371-24-000121.md) | [3.8](/filings/0000721371-25-000013.md) | [3.3](/filings/0000721371-25-000038.md) | [3.9](/filings/0000721371-26-000038.md) | [4.6](/filings/0000721371-25-000130.md) | [2.8](/filings/0000721371-26-000006.md) | [4.9](/filings/0000721371-26-000038.md) |
| Current assets | $bn | [33.7](/filings/0000721371-24-000056.md) | [34.7](/filings/0000721371-23-000084.md) | [37.7](/filings/0001628280-24-002813.md) | [35.7](/filings/0000721371-24-000038.md) | [34.9](/filings/0000721371-25-000079.md) | [32.9](/filings/0000721371-24-000121.md) | [35.8](/filings/0000721371-25-000013.md) | [34.6](/filings/0000721371-25-000038.md) | [36.4](/filings/0000721371-26-000038.md) | [38.5](/filings/0000721371-25-000130.md) | [39.2](/filings/0000721371-26-000006.md) | [38.8](/filings/0000721371-26-000038.md) |
| Total assets | $bn | [43.3](/filings/0000721371-24-000056.md) | [43.7](/filings/0000721371-23-000084.md) | [46.6](/filings/0001628280-24-002813.md) | [45.9](/filings/0000721371-24-000038.md) | [45.1](/filings/0000721371-25-000079.md) | [43.1](/filings/0000721371-24-000121.md) | [47.0](/filings/0000721371-25-000013.md) | [49.9](/filings/0000721371-25-000038.md) | [53.1](/filings/0000721371-26-000038.md) | [55.2](/filings/0000721371-25-000130.md) | [58.1](/filings/0000721371-26-000006.md) | [57.3](/filings/0000721371-26-000038.md) |
| Current liabilities | $bn | [33.7](/filings/0000721371-24-000056.md) | [35.1](/filings/0000721371-23-000084.md) | [38.3](/filings/0001628280-24-002813.md) | [36.3](/filings/0000721371-24-000038.md) | [35.6](/filings/0000721371-25-000079.md) | [34.7](/filings/0000721371-24-000121.md) | [35.2](/filings/0000721371-25-000013.md) | [36.7](/filings/0000721371-25-000038.md) | [38.9](/filings/0000721371-26-000038.md) | [40.3](/filings/0000721371-25-000130.md) | [43.3](/filings/0000721371-26-000006.md) | [43.9](/filings/0000721371-26-000038.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [(3.0)](/filings/0000721371-24-000056.md) | [(3.5)](/filings/0000721371-23-000084.md) | [(3.4)](/filings/0001628280-24-002813.md) | [(3.3)](/filings/0000721371-24-000038.md) | [(3.2)](/filings/0000721371-25-000079.md) | [(3.3)](/filings/0000721371-24-000121.md) | [(3.0)](/filings/0000721371-25-000013.md) | [(2.9)](/filings/0000721371-25-000038.md) | [(2.8)](/filings/0000721371-26-000038.md) | [(2.9)](/filings/0000721371-25-000130.md) | [(2.9)](/filings/0000721371-26-000006.md) | [(2.9)](/filings/0000721371-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-03-31) | Q4 FY2023 (2023-06-30) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,361 d](/filings/0000721371-24-000038.md) | [863 d](/filings/0000721371-25-000079.md) | [528](/filings/0000721371-24-000121.md) | [1,179 d](/filings/0000721371-25-000013.md) | [(27.0) d](/filings/0000721371-25-000038.md) | [2,082 d](/filings/0000721371-26-000038.md) | [(1,647)](/filings/0000721371-25-000130.md) | [(396) d](/filings/0000721371-26-000006.md) | [2,913 d](/filings/0000721371-25-000038.md) | [1,527 d](/filings/0000721371-26-000038.md) | [973](/filings/0000721371-25-000130.md) | [686 d](/filings/0000721371-26-000006.md) |
| Capital expenditure | $m | [109 d](/filings/0000721371-24-000038.md) | [217 d](/filings/0000721371-25-000079.md) | [92.0](/filings/0000721371-24-000121.md) | [114 d](/filings/0000721371-25-000013.md) | [112 d](/filings/0000721371-25-000038.md) | [193 d](/filings/0000721371-26-000038.md) | [90.0](/filings/0000721371-25-000130.md) | [99.0 d](/filings/0000721371-26-000006.md) | [126 d](/filings/0000721371-25-000038.md) | [232 d](/filings/0000721371-26-000038.md) | [108](/filings/0000721371-25-000130.md) | [131 d](/filings/0000721371-26-000006.md) |
| Dividends paid | $m | [128 d](/filings/0000721371-24-000038.md) | [126 d](/filings/0000721371-25-000079.md) | [131](/filings/0000721371-24-000121.md) | [124 d](/filings/0000721371-25-000013.md) | [122 d](/filings/0000721371-25-000038.md) | [122 d](/filings/0000721371-26-000038.md) | [128](/filings/0000721371-25-000130.md) | [122 d](/filings/0000721371-26-000006.md) | [124 d](/filings/0000721371-25-000038.md) | [120 d](/filings/0000721371-26-000038.md) | [129](/filings/0000721371-25-000130.md) | [122 d](/filings/0000721371-26-000006.md) |
| Share repurchases | $m | [250 d](/filings/0000721371-24-000038.md) | [500 d](/filings/0000721371-25-000079.md) | [500](/filings/0000721371-24-000121.md) | [250 d](/filings/0000721371-25-000013.md) | [0.0 d](/filings/0000721371-25-000038.md) | [0.0 d](/filings/0000721371-26-000038.md) | [375](/filings/0000721371-25-000130.md) | [15.0 d](/filings/0000721371-26-000006.md) | [375 d](/filings/0000721371-25-000038.md) | [0.0 d](/filings/0000721371-26-000038.md) | [375](/filings/0000721371-25-000130.md) | [383 d](/filings/0000721371-26-000006.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-03-31) | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [275](/filings/0001628280-23-015775.md) | [273](/filings/0000721371-23-000084.md) | [261](/filings/0001628280-24-002813.md) | [258](/filings/0000721371-24-000038.md) | [249](/filings/0000721371-24-000121.md) | [246](/filings/0000721371-25-000013.md) | [245](/filings/0000721371-25-000038.md) | [245](/filings/0000721371-25-000130.md) | [243](/filings/0000721371-26-000006.md) | [241](/filings/0000721371-25-000038.md) | [239](/filings/0000721371-25-000130.md) | [237](/filings/0000721371-26-000006.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 232,575,728 at 2026-07-31, from the cover of the [10-K filed 2026-08-11](/filings/0000721371-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.